Farshchian’ talk presents current evidence on the properties of human derived mesenchymal stem cells, including origin, proliferative potential, plasticity, stability of cells and their viability, use of the MSC from basic science all the way to the clinical setting such as neurodegenerative disease and improve of immunomodulatory activity. A review of preclinical studies and clinical trials using this cell type is performed. Prospects for the use of mesenchymal stem cells, in cell transplantation are associated with the need for specialized collection of MSC and biobanking and transplant criteria.
A.J. Farshchian MD (born April 2, 1962) is a medical doctor, medical author and humanitarian in Miami Florida. He is director of The Center for Regenerative Medicine, which he founded in 2000 in order to pursue pioneering regimens in the treatment of arthritis and neurodegenerative diseases. He coined the term “orthopedic regenerative medicine” to characterize his groundbreaking work. In 2005 he performed the first autologous stem cell transplantation into an arthritic knee in U.S.A. For the 2012 London Olympics and 2016 Rio Olympics, Farshchian served as consulting Orthopedic Regenerative Medicine physician for the Team USA track-and-field team.
Find out how regenerative therapies can help you grow your practice